Twist Bioscience Responds to Agilent’s Latest Baseless Complaint

AUG 22, 2018 Download PDF Agilent’s wholesale shift in its allegations, two and a half years into its suit, reveals only the weakness of its claims. Agilent’s most recent allegations are gamesmanship, not substance.  They omit that more than four months before it sought to change its complaint, Twist informed – and provided to Agilent – the... Read more

Agena Bioscience Announces Collaboration with PerkinElmer

21 August 2018 Combining LabChip® GX Touch Nucleic Acid Analyzer and MassARRAY® for Optimized Liquid Biopsy Workflow San Diego, CA – Agena Bioscience (Agena) announced today that they have entered into a collaboration with PerkinElmer, incorporating the LabChip® GX Touch™ nucleic acid analyzer for quality assessment and quantitation of DNA in the upfront workflow of Agena’s MassARRAY®system. The... Read more

Illumina Announces Pricing of Convertible Senior Notes

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (Nasdaq: ILMN) today announced the pricing of an offering of $650 million aggregate principal amount of its 0.0% convertible senior notes due 2023 (the “Notes”). The Notes are being offered to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Illumina has... Read more

Tecan accelerates broad genomics strategy with the acquisition of NuGEN Technologies

August 16, 2018 Acquisition of US-based NuGEN expands Tecan’s dedicated solutions offering into new market segment of next-generation sequencing (NGS) reagents and increases overall recurring revenues NuGEN provides innovative NGS kits and genomic sample prep reagents for the fastest growing field within the genomics area NuGEN to become part of Tecan’s Life Sciences Business, leveraging Tecan’s... Read more

Merck KGaA, Darmstadt, Germany, Awarded Australian CRISPR Nickase Patent for Foundational Genome-Editing Technology

Merck KGaA, Darmstadt, Germany, today announced that the Australian Patent Office has allowed the company’s patent application for the use of paired CRISPR nickases. 15 AUG 2018 | DARMSTADT, GERMANY Patent covers paired Cas9 nickase technology to reduce off-target effects, advance gene therapy and research Expands company’s foundational CRISPR cutting and integration IP necessary to correct genetic... Read more

Gyros Protein Technologies introduces Gyrolab CHO-HCP E3G Kit for impurity testing of biotherapeutics

Incorporates Cygnus Technologies’ gold standard reagents Ready-to-use immunoassay kit designed to increase productivity Uppsala, Sweden, 13 August 2018 Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, today introduced Gyrolab® CHO-HCP E3G Kit for impurity analysis in the CMC (chemistry manufacturing and controls) – bioprocess workflow of biotherapeutics.... Read more

GNA Biosolutions wins AACC’s Disruptive Technology Award

Published on August 6, 2018. Chicago, Illinois, August 1, 2018: GNA Biosolutions was named the winner of the American Association of Clinical Chemistry’s (AACC) Disruptive Technology Award competition, held on Monday evening at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo in Chicago, Illinois. The AACC Disruptive Technology Award recognizes innovative testing solutions that... Read more

Pacific Biosciences Appoints Christian Henry to Board of Directors

MENLO PARK, Calif., July 31, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that it has appointed industry veteran Christian Henry to its Board of Directors. Mr. Henry has over 20 years of leadership experience, including over 10 years in... Read more

10x Genomics Partners with BioLegend and Immudex to Extend Research Applications of Its New Single Cell Feature Barcoding Technology

PLEASANTON, CA.—July 31, 2018—10x Genomics, Inc., a company focused on accelerating genomic discovery, today announced that BioLegend and Immudex will be the first 10x Compatible Partners providing products for its new single cell Feature Barcoding Technology, which was revealed at the 2018 Advances in Genome Biology and Technology meeting in February this year. The resulting product innovations, available at the end of... Read more

Omniome Completes $60 Million Series B Financing To Advance Novel Genomic Sequencing Technology

SAN DIEGO, July 30, 2018 /PRNewswire/ — Omniome, Inc., developer of an innovative new DNA sequencing platform, today announced it has raised an additional $60 million with the completion of its Series B financing.  The funding round was led by Decheng Capital and Hillhouse Capital Group, joined by Lam Research Capital and Nan Fung Life Sciences as well as... Read more